Table 1.
Demographics of Doxycycline Treated and Control Study Populations
| Doxycycline n=20 |
Placebo n=24 |
P-value | |
|---|---|---|---|
| Age (years) | 68.9±1.68 | 74.0±1.5 | 0.0249 |
| Gender (%Males) | 80% | 79.2% | |
| Body Mass Index (kg/m2) | 29.6±1.5 | 27.5±0.8 | |
| Hypertension | 18 (90%) | 19 (79.2%) | |
| Diabetes Mellitus | 2 (10%) | 3 (12.5%) | |
| Coronary Disease | 12 (60%) | 11 (45.8%) | |
| Inflammatory AAA | 0 | 1 (4.2%) | |
| Family History AAA | 1 (5%) | 3 (12.5%) | |
| Peripheral Vascular Disease | 8 (40%) | 7 (29.2%) | |
| Chronic Obstructive Pulmonary Disease |
6 (30%) | 10 (41.7%) | |
| Current Smoker | 13 (65%) | 7 (29.2%) | 0.0324 |
| Renal Insufficiency | 2 (10%) | 6 (25%) | |
| Intestinal Bleed | 4 (20%) | 3 (12.5%) | |
| Aortic Diameter (mm) | 57.2 ± 2.1 | 57.2 ± 2.4 | |
| Hemoglobin (g/dL) | 13.9 ± 0.5 | 13.9 ± 0.3 | |
| Creatinine (mg/dL) | 1.4 ± 0.3 | 1.3 ± 0.2 |